mProX™ Human FYN Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Kinase Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryBased on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.
Product Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
William
Verified Customer
John
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 FYN induces EMT in breast cancer cells.
Vimentin and E-cadherin expression, as well as the distribution and shape of F-actin, were examined using immunofluorescence in FYN-transfected MCF10A and FYN-depleted MDA-MB-231 cells.
Ref: Xie, Ye-Gong, et al. "FYN promotes breast cancer progression through epithelial-mesenchymal transition." Oncology reports 36.2 (2016): 1000-1006.
Pubmed: 27349276
DOI: 10.3892/or.2016.4894
Research Highlights
Comprehending Fyn's function in the onset, advancement, and resistance to anti-cancer therapeutic agents can aid in the creation and application of innovative medications that specifically target Fyn, so improving the management of cancers.
Elias, Daniel, and Henrik J. Ditzel. "Fyn is an important molecule in cancer pathogenesis and drug resistance." Pharmacological research 100 (2015): 250-254.
Pubmed:
26305432
DOI:
10.1016/j.phrs.2015.08.010
Fyn is a cytoplasmic tyrosine kinase (TK) that is non-receptor and a member of the Src family of kinases (SFKs). It is involved in several transduction pathways in the central nervous system (CNS), such as oligodendrocyte development, myelination, axon guidance, and synaptic transmission.
Matrone, Carmela, et al. "Fyn tyrosine kinase as harmonizing factor in neuronal functions and dysfunctions." International journal of molecular sciences 21.12 (2020): 4444.
Pubmed:
32580508
DOI:
10.3390/ijms21124444